Publicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (134)

2024

  1. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

  2. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study

    Circulation: Heart Failure, Vol. 17, Núm. 1, pp. E011105

  3. Timing of coronary angiography and use of antiplatelet pretreatment in patients with NSTEACS in Spain

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 234-242

2023

  1. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  2. Cardiorenal benefits of finerenone: protecting kidney and heart

    Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513

  3. Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry

    Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64

  4. Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

    The American journal of cardiology, Vol. 205, pp. 321-324

  5. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  6. Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

    Journal of Clinical Medicine, Vol. 12, Núm. 12

  7. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  8. Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study

    Thrombosis Journal, Vol. 21, Núm. 1

  9. Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease

    Nefrologia, Vol. 43, Núm. 4, pp. 386-398

  10. Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  11. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  12. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  13. Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 548-554

  14. Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry

    Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 4, pp. 608-619

  15. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  16. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  17. SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion

    Angiology, Vol. 74, Núm. 10, pp. 987-996